JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. (Q37623539)
Jump to navigation
Jump to search
scientific article published on 23 December 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. |
scientific article published on 23 December 2013 |
Statements
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes (English)
Elisa Rumi
Thorsten Klampfl
Nicole C C Them
Tiina Berg
Chiara Elena
Ilaria C Casetti
Emanuela Sant'antonio
Marta Bellini
Maria C Renna
Emanuela Boveri
Cesare Astori
Cristiana Pascutto
Mario Cazzola
Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
1 reference
1 reference
1 reference